Search for: "New Jersey v. Delaware" Results 641 - 660 of 822
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Mar 2010, 5:00 am by Steve McConnell
Look at a map and see how major pharmaceutical companies ring the Delaware Valley and line up from the top of the New Jersey Turnpike down to Wilmington, Delaware. [read post]
19 Mar 2010, 6:31 pm by Sean Wajert
In addition, there are large groups of cases pending in coordinated state-court proceedings in Delaware, New Jersey, and New York. [read post]
18 Mar 2010, 2:30 am
(Patent Docs) Opana (Oxymorphone) - US: District Court New Jersey: Patent infringement complaint following a Paragraph IV Certification: Endo Pharmaceuticals Inc. et al. v. [read post]
4 Mar 2010, 3:17 pm by admin
– EPA News Release, March 3, 2010 A Missouri agricultural merchant has agreed to pay a $14,560 civil penalty to the [read post]
24 Feb 2010, 2:11 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
24 Feb 2010, 2:11 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
21 Feb 2010, 8:31 am
             In the context of the duty of care, the Delaware Supreme Court has defined materiality as any event that is relevant and of such magnitude that directors must take into account in performing their fiduciary duties.[24]             A perfect example of a material risk can be found in Brane v. [read post]
17 Feb 2010, 2:02 pm by David Walk
The plaintiffs in Meng, citizens of Maine and Mississippi, were bellwether plaintiffs in mass tort litigation against Novartis, a company incorporated in Delaware and headquartered in New Jersey. [read post]
11 Feb 2010, 10:22 am by Andrew Russell
Last month, we posted about New Jersey Magistrate Judge Bongiovanni's decision to disqualify a lawyer for a conflict of interest under Rule of Professional Conduct 1.7, in Wyeth and Cordis Corp. v. [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Opana (Oxymorphone) – US: Endo files patent infringement suit against Roxane in response to Para IV challenge (Patent Docs) Ortho Tri-Cyclen Lo (Ethinyl estradiol, norgestimate) – US:Patent infringement complaint filed in New Jersey following a Paragraph IV certification: Ortho-McNeil-Janssen Pharmaceuticals, Inc. v. [read post]
8 Feb 2010, 5:01 am by James Edward Maule
New Jersey cannot require the retailer to pay a sales tax because the sale does not take place in New Jersey, and New Jersey cannot require the retailer to pay a use tax unless the retailer has a sufficient "nexus" (or set of contacts) with New Jersey to justify imposing the tax. [read post]
5 Feb 2010, 9:00 pm by Fred Abrams
The Court announced yesterday that there had been a settlement in the New Jersey case involving Former Premier Michael Misick of the Turks and Caicos Islands. [read post]
3 Feb 2010, 9:39 pm by Andrew Russell
In this particular case Pfizer, a Delaware corporation with its principal place of business in New York, brought an ANDA suit against Sandoz, Inc., a Colorado corporation with its principal place of business in New Jersey, but also with its primary manufacturing plant located in Colorado. [read post]
3 Feb 2010, 2:00 am by Sharon Armstrong
  (Notably, the parties were able to come to an agreement regarding concurrent use of the mark USC in connection with education services, with Southern California taking Washington, Oregon, California, Nevada, Idaho, Arizona, Utah, Colorado, Wyoming, Montana, New Mexico, Texas, North Dakota, South Dakota, Nebraska, Kansas, Oklahoma, Minnesota, Iowa, Missouri, Massachusetts, Illinois, and Hawaii and South Carolina taking Wisconsin, Mississippi, Indiana, Kentucky, Tennessee, Alabama,… [read post]
25 Jan 2010, 5:00 am by Beck, et al.
See “Tort Law – Indirect Reliance – New Jersey Supreme Court Rejects Fraud-On-The-Market Theory,” 114 Harv. [read post]
16 Dec 2009, 11:53 am
In a subsequent 2008 case, a Maryland Court of Appeals (Independent Newspapers, Inc v Zebulon J Brodie)(3) similarly concluded that anonymous posts should be protected and set out an approach first detailed in a New Jersey case(4) describing the steps that judges should take in deciding whether to compel disclosure of anonymous online speakers in future cases. [read post]
9 Dec 2009, 3:59 pm
Immunocorp (PATracer) Lipitor (Atorvastatin) – US: Complaint filed in Delaware - Infringement of US patent following Paragraph IV challenge: Pfizer Inc. et al. v. [read post]
7 Dec 2009, 12:49 pm by Pilar G. Kraman
Judge Bongiovanni indicated that in the District of New Jersey the violation of Rule 1.7 should result in automatic disqualification. [read post]